124 related articles for article (PubMed ID: 6094740)
1. Central nervous system pharmacology of Baker's antifolate (NSC139105) in man.
Stewart DJ; Leavens M; Lu K; Wang YM; Benjamin RS; Ho DH; Yap HY; Loo TL
J Neurooncol; 1984; 2(3):187-93. PubMed ID: 6094740
[TBL] [Abstract][Full Text] [Related]
2. Human central nervous system pharmacology of pentamethylmelamine and its metabolites.
Stewart DJ; Benvenuto JA; Leavens M; Smith RG; Cabanillas F; Benjamin RS; Loo TL
J Neurooncol; 1983; 1(4):357-64. PubMed ID: 6432969
[TBL] [Abstract][Full Text] [Related]
3. Concentration of vinblastine in human intracerebral tumor and other tissues.
Stewart DJ; Lu K; Benjamin RS; Leavens ME; Luna M; Yap HY; Loo TL
J Neurooncol; 1983; 1(2):139-44. PubMed ID: 6678966
[TBL] [Abstract][Full Text] [Related]
4. Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.
Stewart DJ; Benvenuto JA; Leavens M; Hall SW; Benjamin RS; Plunkett W; McCredie KB; Burgess MA; Loo TL
Cancer Res; 1979 Oct; 39(10):4119-22. PubMed ID: 476649
[TBL] [Abstract][Full Text] [Related]
5. Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986).
Savaraj N; Lu K; Feun LG; Leavens ME; Stewart D; Burgess MA; Benjamin RS; Loo TL
J Neurooncol; 1983; 1(1):15-9. PubMed ID: 6678302
[TBL] [Abstract][Full Text] [Related]
6. Comparative distribution of Baker's antifolate (NSC 139105) in rat tissues after subcutaneous and intravenous injections.
Yang BC; Ho DH; Brown NS; Benjamin RS; Bodey GP
J Med; 1980; 11(5-6):413-24. PubMed ID: 6962827
[TBL] [Abstract][Full Text] [Related]
7. Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolate.
Hall SW; Tenczynski TF; Benjamin RS; Burgess MA; Valdivieso M; Loo TL; Bodey GP
Cancer Chemother Pharmacol; 1978; 1(3):139-44. PubMed ID: 373915
[TBL] [Abstract][Full Text] [Related]
8. Penetration of N-(phosphonacetyl)-L-aspartate into human central nervous system and intracerebral tumor.
Stewart DJ; Leavens M; Friedman J; Benjamin RS; Moore EC; Bodey GP; Valdivieso M; Burgess MA; Wiseman C; Loo TL
Cancer Res; 1980 Sep; 40(9):3163-6. PubMed ID: 7427934
[TBL] [Abstract][Full Text] [Related]
9. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.
Stewart DJ; Leavens M; Maor M; Feun L; Luna M; Bonura J; Caprioli R; Loo TL; Benjamin RS
Cancer Res; 1982 Jun; 42(6):2474-9. PubMed ID: 6280860
[No Abstract] [Full Text] [Related]
10. Central nervous system (CNS) penetration of homoharringtonine (HHT).
Savaraj N; Feun LG; Lu K; Leavens M; Moser R; Fields WS; Loo TL
J Neurooncol; 1987; 5(1):77-81. PubMed ID: 3598625
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.
Zhang SR; Zhu LC; Jiang YP; Zhang J; Xu RJ; Xu YS; Xia B; Ma SL
Acta Pharmacol Sin; 2017 Feb; 38(2):233-240. PubMed ID: 27840411
[TBL] [Abstract][Full Text] [Related]
13. Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans.
Rosenblum MG; Stewart DJ; Yap BS; Leavens M; Benjamin RS; Loo TL
Cancer Res; 1981 Feb; 41(2):459-62. PubMed ID: 7448791
[TBL] [Abstract][Full Text] [Related]
14. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinoma.
Zhao J; Chen M; Zhong W; Zhang L; Li L; Xiao Y; Nie L; Hu P; Wang M
Clin Lung Cancer; 2013 Mar; 14(2):188-93. PubMed ID: 22846582
[TBL] [Abstract][Full Text] [Related]
16. Phase I studies with Baker's Antifol (BAF) (NSC 139105).
Rodriguez V; Gottlieb J; Burgess MA; Livingston R; Wheeler W; Spitzer G; Bodey GP; Blumenschein GR; Freireich EJ
Cancer; 1976 Aug; 38(2):690-4. PubMed ID: 974989
[TBL] [Abstract][Full Text] [Related]
17. Brain, CSF, and tumor pharmacokinetics of alpha-difluoromethylornithine in rats and dogs.
Levin VA; Csejtey J; Byrd DJ
Cancer Chemother Pharmacol; 1983; 10(3):196-9. PubMed ID: 6407769
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors.
Baker SD; Heideman RL; Crom WR; Kuttesch JF; Gajjar A; Stewart CF
Cancer Chemother Pharmacol; 1996; 37(3):195-202. PubMed ID: 8529278
[TBL] [Abstract][Full Text] [Related]
19. Whole-brain radiation fails to boost intracerebral gefitinib concentration in patients with brain metastatic non-small cell lung cancer: a self-controlled, pilot study.
Fang L; Sun X; Song Y; Zhang Y; Li F; Xu Y; Ma S; Lin N
Cancer Chemother Pharmacol; 2015 Oct; 76(4):873-7. PubMed ID: 26310285
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and disposition of Baker's antifolate (NSC-139105), ftorafur (NSC-148958), and dichloroallyl lawsone (NSC-126771) in man.
Loo TL; Benjamin RS; Lu K; Benvenuto JA; Hall SW; McKelvey EM
Drug Metab Rev; 1978; 8(1):137-50. PubMed ID: 363378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
